marketing purposes. So we need to have a lot more
information about what happens with this data for us to
get involved with it directly.
➐ The next 5-10 years
Gary Thornton – So what would success look
like, 5-10 years from now, in terms of having
the necessary antibiotics and other health
resources to care for industry flocks?
Dr. Sutherland – Continued availability of existing medically important
antibiotics for therapeutic indications.
A regulatory environment that is open
and receptive and willing to work
with the drug industry to work through
the approval process for novel
non-antibiotic products. And I know that that’s a kind of a
pipe dream in some ways, but we certainly are investing
in those areas to replace the loss of feed efficiency,
growth promotion and produce the protein demands
that are really high and getting greater all the time on a
global basis. I think we also need a regulatory environment that continues to allow the approval of non-medical
antibiotics for treatment indication. Then I guess another
key factor is communication, close cooperation between
the pharmaceutical industry, the poultry industry, the
veterinarians and FDA. Together I think we’re going to
be a lot more successful for all working together.
Dr. Singer – If we’re going to address this issue of antimi-
crobial resistance and get a handle on it, we need to have
a systematic way of monitoring how it’s changing with
time. There’s a lot of concern within the animal industry
of participating in these kinds of monitoring programs
because the data often are used in political science – a
blame game. I would love to see us 5-10 years from
now in a situation where the industries can collaborate
in these kinds of monitoring programs and know that
they’re being proactive and part of the solution.